{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:45:12Z","timestamp":1764701112594},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,19]]},"DOI":"10.7759\/cureus.56439","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T08:40:47Z","timestamp":1710837647000},"source":"Crossref","is-referenced-by-count":1,"title":["Two Incidental Sibling Diagnoses of Netherton Syndrome in Separate Visits: A Case Report"],"prefix":"10.7759","author":[{"given":"Samah","family":"AlMoosawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Alkhanaizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Albaharna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatema","family":"Khamdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-73650-6","article-title":"The Ichthyoses: A Guide to Clinical Diagnosis, Genetic Counseling, and Therapy","author":"Traupe H","year":"1989","unstructured":"Traupe H. The Ichthyoses: A Guide to Clinical Diagnosis, Genetic Counseling, and Therapy. Springer Berlin, Heidelberg, Germany; 1989. 10.1007\/978-3-642-73650-6"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01389.x","article-title":"The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis","volume":"117","author":"Sprecher E","year":"2001","unstructured":"Sprecher E, Chavanas S, DiGiovanna JJ, et al.. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest Dermatol. 2001, 117:179-87. 10.1046\/j.1523-1747.2001.01389.x","journal-title":"J Invest Dermatol"},{"key":"ref3","article-title":"Dermatology E-Book, 4th Edition","author":"Bolognia J","year":"2018","unstructured":"Bolognia J, Schaffer JV, Cerroni L. Dermatology E-Book, 4th Edition. Elsevier, New York, NY; 2018."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.019","article-title":"An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis","volume":"139","author":"Paller AS","year":"2017","unstructured":"Paller AS, Renert-Yuval Y, Suprun M, et al.. An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis. J Allergy Clin Immunol. 2017, 139:152-65. 10.1016\/j.jaci.2016.07.019","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000084755","article-title":"Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5","volume":"210","author":"Geyer AS","year":"2005","unstructured":"Geyer AS, Ratajczak P, Pol-Rodriguez M, Millar WS, Garzon M, Richard G. Netherton syndrome with extensive skin peeling and failure to thrive due to a homozygous frameshift mutation in SPINK5. Dermatology. 2005, 210:308-14. 10.1159\/000084755","journal-title":"Dermatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.645259","article-title":"Netherton syndrome in children: management and future perspectives","volume":"9","author":"Barbati F","year":"2021","unstructured":"Barbati F, Giovannini M, Oranges T, et al.. Netherton syndrome in children: management and future perspectives. Front Pediatr. 2021, 9:10.3389\/fped.2021.645259","journal-title":"Front Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01663.x","article-title":"Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides","volume":"118","author":"Komatsu N","year":"2002","unstructured":"Komatsu N, Takata M, Otsuki N, Ohka R, Amano O, Takehara K, Saijoh K. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol. 2002, 118:436-43. 10.1046\/j.0022-202x.2001.01663.x","journal-title":"J Invest Dermatol"},{"key":"ref8","unstructured":"Orphanet. Netherton syndrome. (2023). Accessed: November 1, 2023: https:\/\/www.orpha.net\/en\/disease\/detail\/634."},{"key":"ref9","article-title":"Peeling skin syndromes","author":"Sprecher E","year":"2024","unstructured":"Sprecher E, Samuelov L. Peeling skin syndromes. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2024."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.07.005","article-title":"Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease","volume":"87","author":"Oji V","year":"2010","unstructured":"Oji V, Eckl KM, Aufenvenne K, et al.. Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Am J Hum Genet. 2010, 87:274-81. 10.1016\/j.ajhg.2010.07.005","journal-title":"Am J Hum Genet"},{"key":"ref11","unstructured":"DermNet. Netherton syndrome. (2023). Accessed: November 24, 2023: https:\/\/dermnetnz.org\/topics\/netherton-syndrome."},{"key":"ref12","article-title":"Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome","volume":"137","author":"Allen A","year":"2001","unstructured":"Allen A, Siegfried E, Silverman R, et al.. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol. 2001, 137:747-50.","journal-title":"Arch Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.326","article-title":"The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study","volume":"146","author":"Yan AC","year":"2010","unstructured":"Yan AC, Honig PJ, Ming ME, Weber J, Shah KN. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. Arch Dermatol. 2010, 146:57-62. 10.1001\/archdermatol.2009.326","journal-title":"Arch Dermatol"},{"key":"ref14","unstructured":"GARD rare disease information - Netherton syndrome. (2023). Accessed. November 30, 2023: https:\/\/rarediseases.org\/gard-rare-disease\/netherton-syndrome\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/213764-two-incidental-sibling-diagnoses-of-netherton-syndrome-in-separate-visits-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T08:40:53Z","timestamp":1710837653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/213764-two-incidental-sibling-diagnoses-of-netherton-syndrome-in-separate-visits-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.56439","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,19]]}}}